Loading
Insider filings for Recipharm AB (publ) are scarce in the Finansinspektionen feed, the latest one published on 3 January 2021. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
· cache
2 of 2 declarations
Recipharm AB is a Swedish pharmaceutical company specializing in contract manufacturing of medicines. It is listed on the Stockholm Stock Exchange.